Cancer Australia acknowledges the significant input and valuable advice extended to the agency by strategic and tumour specific advisory groups.
Cancer Australia’s Advisory Group structure supports the agency’s leadership role in national cancer control and the delivery of the goals outlined in the Cancer Australia Strategic Plan 2014-2019, namely, Shape national cancer control in Australia; Improve cancer outcomes; Inform effective and sustainable cancer care; and Strengthen capability for national cancer control.
Group members represent a broad range of expertise, experiences and sectors, including policy, research, health promotion and communication. Consumers are represented on all Cancer Australia Advisory Groups.
Cancer Australia values the advice and support extended to the organisation by the following strategic Advisory Groups:
- Research and Data Advisory Group
- Intercollegiate Advisory Group
- Breast Cancer Advisory Group
- Gynecological Cancer Advisory Group, and
- Lung Cancer Advisory Group.
Research and Data Advisory Group
The Research and Data Advisory Group provides expert advice to Cancer Australia about the strategic priority areas in cancer research and data in line with the Cancer Australia Strategic Plan 2014-2019.
Members provide expert advice and overall direction on research and data including: current and emerging issues in national and international cancer research and clinical trials; priorities for cancer research in Australia; national coordination and data linkage; a strategic approach to national cancer data monitoring and reporting; strategies to improve Australia’s overall cancer research and data capacity; key national and international partnerships and collaborations which support Cancer Australia’s leadership role in research and data, and future Cancer Australia research and data initiatives.
The group is chaired by Professor Adele Green who commenced as Chair in November 2014.
Intercollegiate Advisory Group
The Intercollegiate Advisory Group provide advice across the spectrum of cancer control to inform national approaches to reduce variations in cancer outcomes; identifies the use of best available evidence to achieve affective cancer care; identify collaborative approaches across the system to address cancer control challenges; and provide advice on emerging issues nationally and internationally to inform Cancer Australia work.
The group is chaired by A/Professor Chris Milross who commenced as Chair in August 2014.
Breast Cancer Advisory Group
The Breast Cancer Advisory Group provides expert advice on the prioritisation, development and implementation of Cancer Australia’s breast cancer initiatives; coordinated, multidisciplinary and patient-centred approaches to breast cancer care; and identification of gaps and barriers in the provision of best practice cancer care.
The group is chaired by Associate Professor Bruce Mann. who commenced as Chair in July 2015.
Gynecological Cancer Advisory Group
The role of the Gynecological Cancer Advisory Group is to identify and advise on best practice initiatives, barriers, opportunities, strategies and actions relating to issues of national relevance to gynecological cancers. The group also identifies ways in which Cancer Australia can work effectively with all stakeholders including consumers, cancer organisations and professional groups to determine approaches in each of these areas to lessen the impact of gynecological cancers in Australia.
The group is chaired by Professor Michael Quinn AM who commenced as Chair in November 2016.
Lung Cancer Advisory Group
The role of the Lung Cancer Advisory Group is to provide Cancer Australia with expert advice regarding the issues and activities related to lung cancer. The group informs priorities of Cancer Australia’s program of work in lung cancer; provides strategic guidance and expertise in relation to specific projects; and identifies barriers to optimal cancer control and collaborative opportunities to assist in advancing national lung cancer control activities.
The group is chaired by Professor David Ball who commenced as Chair in November 2013.